CTChristopher P. Tostado

Christopher P. Tostado

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christopher P. Tostado has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Carlo Miccolis

    Genome Institute of Singapore, Laboratory of Precision Oncology and Cancer Evolution Singapore Singapore

    1 shared publication
  • Jia Wei Joel Heng

    Genome Institute of Singapore, Laboratory of Precision Oncology and Cancer Evolution Singapore Singapore

    1 shared publication
  • Justine Jia Wen Seow

    Genome Institute of Singapore, Laboratory of Precision Oncology and Cancer Evolution Singapore Singapore

    1 shared publication
  • Lucas Xian Da Ong

    Institute for Health Innovation and Technology (iHealthtech), National University of Singapore Singapore Singapore

    1 shared publication
  • Ramanuj DasGupta

    Laboratory of Tumour Evolution, University of Glasgow, Glasgow, UK

    1 shared publication
  • Shumei Chia

    Genome Institute of Singapore, Laboratory of Precision Oncology and Cancer Evolution Singapore Singapore

    1 shared publication

Latest Publications

  • Open Access

    An AI‐assisted integrated, scalable, single‐cell phenomic‐transcriptomic platform to elucidate intratumor heterogeneity against immune response

    by Christopher P. Tostado, Lucas Xian Da Ong, Joel Jia Wei Heng, Carlo Miccolis, Shumei Chia, Justine Jia Wen Seow, Yi‐Chin Toh, Ramanuj DasGupta

    We present a novel framework combining single‐cell phenotypic data with single‐cell transcriptomic analysis to identify factors underpinning heterogeneity in antitumor immune response. We developed a pairwise, tumor‐immune discretized interaction assay between natural killer (NK‐92MI) cells and patient‐derived head and neck squamous cell carcinoma (HNSCC) cell lines on a microfluidic cell‐trapping platform. Furthermore we generated a deep‐learning computer vision algorithm that is capable of automating the acquisition and analysis of a large, live‐cell imaging data set (>1 million) of paired tumor‐immune interactions spanning a time course of 24 h across multiple HNSCC lines (n = 10). Finally, we combined the response data measured by Kaplan–Meier survival analysis against NK‐mediated killing with downstream single‐cell transcriptomic analysis to interrogate molecular signatures associated with NK‐effector response. As proof‐of‐concept for the proposed framework, we efficiently identified MHC class I‐driven cytotoxic resistance as a key mechanism for immune evasion in nonresponders, while enhanced expression of cell adhesion molecules was found to be correlated with sensitivity against NK‐mediated cytotoxicity. We conclude that this integrated, data‐driven phenotypic approach holds tremendous promise in advancing the rapid identification of new mechanisms and therapeutic targets related to immune evasion and response.